Dry Age Related Macular Degeneration

Overview of mild, moderate and severe dry AMD including drusen and geographic atrophy.

What are Drusen?

The hallmark of dry AMD is macular drusen (see photo). Drusen are made up of lipids, a type of fatty protein. They may be the result of a failure of the eye to dispose of waste products that are produced when the photoreceptors of the eye drop off older parts of the cell. There are several types of drusen with different levels of risk. Drusen can be small, hard and scattered far apart from each other. They are round and distinct. This type may not create vision problems for a long time and may not even be an indication of macular degeneration. Some drusen can become larger, softer and closer together. Their edges are less distinct. When they get to that stage, there is a greater risk for developing wet macular degeneration and more severe vision loss. They can also disrupt the layers of the retina and may lead to retinal pigment epithelium detachment (PED). Your doctor can see these drusen during a dilated eye exam, even if you are not aware of a vision change. That is one reason why regular eye exams are so important. If you have the larger, soft drusen, your doctor will probably want you to come into the office for check-ups more often. If they do lead to wet macular degeneration, early treatment is essential.

What is Geographic Atrophy?

Geographic atrophy occurs when the photoreceptors (seeing part of the retina) no longer works and the patient develops a blind spot or spot of poor vision in the macula (see photo). Geographic atrophy (GA) is considered the late stage of the dry form of Age-related Macular Degeneration (AMD). It only occurs in about 10 percent of dry AMD patients. GA is usually a sharply delineated round or oval area of hypopigmentation, or apparent absence of the retinal pigment epithelium (RPE), in which choroidal vessels are more visible than in surrounding areas The most common sequence of events leading to GA is the progression of a large drusen to hyperpigmentation, followed by regression of the drusen, hypopigmentation and ultimately RPE cell death, with development of an atrophic area of retina and underlying choriocapillaris, sometimes preceded by the appearance of refractile deposits. This usually takes more than 5 years. Less frequently, GA can follow a drusenoid RPE detachment, regression of a CNV membrane or a RPE rupture. As other forms of late AMD, GA tends to be bilateral (over 50% of cases) and there is high symmetry between eyes for total atrophic area, presence of peripapillary atrophy and enlargement rate. GA often first develops surrounding the fovea, sparing the central area.

What is Progressive Geographic Atrophy?

Geographic atrophy can progress and lead to vision loss. When people with dry AMD lose vision, it is almost always from geographic atrophy. The animated image with this text shows growing geographic atrophy over 3 years in an 86 year old patient. This person is fortunate to have good vision because the dark areas of geographic atrophy are not yet affecting the central vision. Given the progression, the central vision will likely be affected within about 10 years. The images are fundus autofluorescent images that are useful for following geographic atrophy because the atrophy shows up as well delineated dark spots.

What is Pattern Dystrophy?

Pattern dystrophy is a type of dry age-related macular degeneration that involves mostly the very center of the macula. There are several types of pattern dystrophy. The image with this text is of a patient with adult vitelliform macular dystrophy. The image shows the buildup of abnormal deposits under the retina in the center of the macula. Unlike typical dry macular degeneration where the buildup of material is below the retinal pigment epithelium, in pattern dystrophy, the buildup of material is above the pigment epithelium and directly beneath the retina (see asterisks on image). Pattern dysrophy is autosomal dominant, usually presents at a younger age than typical dry AMD, and usually does not progress to wet AMD.

Pattern Dystrophy

What about Diet?

Patients who consume fruits and vegetables have the lowest rates of macular degeneration development. Lutein, a carotenoid pigment found exclusively in fruit and vegetables, serves as the primary protector of the eye. Lutein accumulates in the macula and likely blocks the damage caused by sunlight, one proposed cause of AMD. Fruits and vegetables are also high in antioxidant vitamins such as Beta- carotene, Vitamin E, and Vitamin C. Green leafy vegetables and other colorful foods like kiwi, squash, red grapes, and corn are good sources of Lutein. Other dietary habits have been shown to increase the risk of AMD. Individuals with a higher percentage of vegetable, monounsaturated, and polyunsaturated fats in their diet have higher rates of Wet AMD development. Diets rich in Omega 3 fatty acids reduce the risk of vision loss. These are found naturally in cold-water fish such as salmon and tuna, and in flaxseeds and flaxseed oil. Two servings of fish per week are adequate.

What about Vitamins?

The Age-Related Eye Disease Study 2 showed that among people at high risk for developing late-stage, or wet, macular degeneration (such as those who have large amounts of drusen or who have significant vision loss in at least one eye), taking a dietary supplement of vitamin C, vitamin E, lutein and zeaxanthin, along with zinc, lowered the risk of macular degeneration progressing to advanced stages by at least 25 percent. The supplements did not appear to provide a benefit for people with minimal macular degeneration or people without evidence of the disease during the course of the study. These vitamins contain a mixture of Vitamins C and E, Lutein, Zeaxanthin, Zing and Copper. Another large study in women showed a benefit from taking folic acid and vitamins B6 and B12. It is very important to remember that vitamin supplements are not a cure for macular degeneration, nor will they give you back vision that you may have already lost from the disease. However, these supplements do play a key role in helping some people at high risk for developing advanced (wet) AMD to maintain their vision, or slow down the progression of the disease.

What about Amsler Grid?

One of the first signs of macular degeneration can be wavy, broken or distorted lines OR a blurred or missing area of vision. The Amsler Grid can help you spot these early. Early detection of wet AMD is critical because laser treatment, when indicated, is most successful when performed before damage occurs. Since dry AMD can lead to development of wet AMD, most patients should use the Amsler Grid. Check with your eye doctor to find out how often you should use this test. Wear your reading glasses, if you normally use them and sit about 14 inches away from the screen. Check one eye at a time. Cover the eye you are not testing. Focus on the dark dot in the center of the grid. While looking at this dot, you still should be aware of the lines of the grid. Notice if any of the lines are distorted or broken or if there are blurred areas.

Download Amsler Grid

Dry Macular Degeneration NEWS

Below are current articles from a Google News Feed on Dry Macular Degeneration

What's the Difference Between Dry and Wet Age-Related Macular Degeneration?  U.S. News & World Report

Learn how dry (atrophic) and wet (neovascular or exudative) macular degeneration differ in symptoms and treatment options.

Focusing the battle against dry AMD  Modern Retina

Age-related macular degeneration (AMD) is the leading cause of blindness worldwide. Currently, there are no treatments for dry AMD, a debilitating form of the ...

OpRegen appears well tolerated in dry AMD  Healio

COEUR D'ALENE, Idaho — In patients with dry age-related macular degeneration, the implantation of human embryonic stem cell-derived retinal pigment ...

A Patient's Guide to Macular Degeneration  U.S. News & World Report

Learn about the symptoms, causes and treatment options in the macular degeneration condition guide at U.S. News and World Report.

The new gene therapy that could help save sight  Medical Xpress

A new gene therapy being developed at The Australian National University (ANU) will help people at risk of dry age-related macular degeneration (AMD) and ...

Would you implant a multifocal IOL in a patient with age-related macular degeneration?  Healio

Ocular Surgery News | Patients with macular degeneration experience great frustration. They are losing their independence and their ability to read. Often they ...

Age-related Macular Degeneration (AMD) Treatment Technology Market Projected to Witness a Single-Digit CAGR During 2017-2025  Rapid News Network

Age-related macular degeneration (AMD) is a health issue associated with the retina. According to the National Medical Research Council (Singapore), ...

Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept  MD Linx

In this retrospective, interventional, consecutive case series involving 313 patients (313 eyes), researchers examined the features of patients who developed ...

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency  Healio

Education Lab | The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction of intravitreal ...

Injection could slow macular degeneration  7NEWS

Canberra-based researchers are developing a new gene therapy that involves an injection to stop the progress of dry age-related macular degeneration.

Gyroscope Targeting 'Huge' Population With Dry AMD Gene Therapy  Scrip

Bringing gene therapy to the masses: company raises extra £50m in series B fundraising for novel dry macular degeneration treatment. Existing Subscriber?

Diagnose AMD earlier with dark adaptation testing  Healio

Primary Care Optometry News | An immediate referral to a retina specialist due to a bleed is a tense circumstance for all involved. However, I have learned ...

Smoggy Air Might Contribute to Macular Degeneration | Health News  U.S. News & World Report

By Robert Preidt, HealthDay Reporter. (HealthDay). WEDNESDAY, Aug. 21, 2019 (HealthDay News) -- Tailpipe pollution might pose a real health threat to aging ...

Phase 2 Study Published in Ophthalmology Highlights Efficacy and Safety Data of Intravitreal APL-2 for Geographic Atrophy Secondary to Age-Related Macular Degeneration  GlobeNewswire

CRESTWOOD, Ky., and WALTHAM Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (NASDAQ:APLS) a clinical-stage ...

Ophthalmologist who misled patients about treatment benefits is struck off  The BMJ

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5648 (Published 19 September 2019) Cite this as: BMJ 2019;366:l5648. Article · Related *content* · Metrics ...

Video: Midday Medical: Macular Degeneration treatment concerns  KWQC-TV6

Dr. Yasser Elshatory with Eye Surgeons Associates shares concerns about a laser treatment being used by a doctor in Oregon.

Opthea's Lucentis/VEGF 'trap' combo outshines Lucentis alone in wet AMD  FierceBiotech

Opthea tested two doses of its drug, OPT-302, in combination with Lucentis, finding that the combo bested Lucentis alone at improving vision and reducing ...

Gyroscope Targets Age-Related Blindness with €55M Series...  Labiotech.eu

UK gene therapy biotech Gyroscope Therapeutics has secured €55.4M in Series B funding to target age-related macular degeneration.

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion  BioSpace

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting ...

Australian scientist identifies molecule that can stop dry AMD  Insight News

A Canberra researcher is working on ways to harness gene-regulating molecules that have shown promise in halting the progression of conditions such as ...

Santen microshunt study results lead news of the week  Healio

Here are some of the past week's top stories on Healio.com/OSN:

Pixium Vision to Participate in Multiple Upcoming Industry Events  GlobeNewswire

Pixium Vision to Participate in Multiple Upcoming Industry Events. Paris, 5 September 2019 – 5:45 PM CEST - Pixium Vision (FR0011950641 - PIX), ...

FDA, European Medicines Agency advance abicipar pegol applications for wet AMD  Healio

The FDA has accepted a biologics license application and the European Medicines Agency has validated a marketing authorization application for abicipar ...

What Is the Difference Between Wet or Dry Macular Degeneration?  University of Michigan Health System News

Dry macular degeneration occurs when cells of the macula begin to thin and break down. It is characterized by drusen buildup and typically worsens over time.

Meta-analysis on DME treatments updated to include treatment regimen  Modern Retina

The choice of which anti-vascular endothelial growth factor (VEGF) agent to use on patients with diabetic macular edema (DME) may depend on a variety of ...

Apellis up 2% on mid-stage APL-2 data in GA  Seeking Alpha

Apellis Pharmaceuticals (APLS +2.4%) is up on average volume on the heels of results from a Phase 2 clinical trial, FILLY, evaluating lead candidate APL-2 ...

Allegro Ophthalmics to Present the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the 19th EURETINA Congress and The Retina Society 2019 Annual Meeting  Business Wire

Allegro Ophthalmics announced that results of its risuteganib US Phase 2 dry AMD study will be presented at EURETINA and The Retina Society meeting.

Adverum Reports Data From Phase I Wet AMD Study, Stock Down  Yahoo Finance

Adverum Biotechnologies (ADVM) announces data from one cohort of an early-stage study, evaluating its gene therapy candidate, ADVM-022, in patients with ...

Risuteganib for Patients with Dry Age-Related Macular Degeneration  MD Magazine

Peter Kaiser, MD, presented data from a phase 2 trial examining the safety and efficacy of risuteganib at ASRS 2019.

Does This Macular Degeneration Study Deserve More Credit?  24/7 Wall St.

Adverum Biotechnologies Inc. (NASDAQ: ADVM) shares dropped sharply on Thursday after the firm announced data from its Optic Phase 1 clinical trial in wet ...

Research targeting vision loss topic of Latrobe Lions program  TribLIVE High School Sports Network

The CEO of the Eye and Ear Foundation of Pittsburgh will visit Latrobe later this month to provide an update on local research that is under way to combat ...

Surgeon's patients were 'deliberately misled'  BBC News

A surgeon who "put financial interests before patients" has been struck off. Bobby Qureshi cultivated a high media profile as an eye expert and featured patients ...

FDA Accepts BLA for Abicipar Pegol for Neovascular Age-Related Macular Degeneration  Monthly Prescribing Reference

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for abicipar pegol (Allergan), an investigational DARPin ...

Wet AMD gene therapy well tolerated through 3 years  Healio

Patients with wet age-related macular degeneration who responded well to rAAV.sFLT-1 subretinal gene therapy at 1 year maintained that response through 3 ...

Expert panel in macular degeneration recommends paradigm shift for future directions  Medical Xpress

A panel of investigators assembled by the National Advisory Eye Council (NAEC) calls for large-scale collaborative research to address dry macular ...

How the menopause could be wrecking your eye health  woman&home

The menopause can inundate us with ailments; hot flushes, sleepness nights, hair loss – the list goes on. But its impact on our eyes can be significant too.

Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration—An Eye Toward the Future: What Is on the Horizon in nAMD?  Healio

Nancy M. Holekamp, MD Professor of Clinical Ophthalmology Washington University School of Medicine St Louis, MO Director, Retina *Service* Pepose Vision ...

Juvenile Macular Degeneration Treatment Market to Witness Relatively Significant Revenue Growth During 2019–2025  Market Segment

“Market Overview of the Report 2025: The report on global Juvenile Macular Degeneration Treatment Market offers high-quality, proven, and wide-ranging ...

Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®  Odessa American

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical ...

Apellis Pharmaceuticals (APLS) Reports Publication of Ph. 2 Study Highlighting Efficacy /7 Safety Data of Intravitreal APL-2 for Geographic Atrophy Secondary to AMD  StreetInsider.com

Apellis Pharmaceuticals Inc., (NASDAQ: APLS) today announced details about its Phase 2 FILLY study investigating intravitreal (IVT) APL-2 (pegcetacoplan) for ...

Biosynthetic RPE monolayer for advanced dry AMD feasible, well-tolerated  Healio

CHICAGO — It is feasible and safe to surgically implant an investigational human embryonic stem cell derived RPE monolayer on an ultrathin synthetic substrate ...

7 Tips to Stop Macular Degeneration  Healthline

Macular degeneration is one of the leading causes of blindness in the United States. Here's how to keep your vision safe while enjoying the sun this spring ...

Report: Dry AMD requires broad, systems biology approach leveraging big data, multiple disciplines  National Institutes of Health

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration (AMD) – a ...

Luminate meets primary endpoint in phase 2 trial for dry AMD  Healio

A treatment candidate for dry age-related macular degeneration met its primary endpoint in a phase 2 study, with 48% of patients gaining at least eight letters of ...

Review of Neovascular Age-Related Macular Degeneration Treatment Options  AJMC.com Managed Markets Network

Due to an aging population, visual impairment from neovascular age-related macular degeneration (nAMD) is increasing in the United States. Despite ...

Scientists make major breakthrough in understanding common eye disease  Science Daily

Scientists have announced a major breakthrough with important implications for sufferers of a common eye disease -- dry Age-Related Macular Degeneration ...

What Is Age-Related Macular Degeneration?  Next Avenue

Age-related macular degeneration (AMD) causes deterioration of the macula, the part of the eye that provides sharp, clear, straight-ahead vision. As many Here ...

Miami student wins grant to study treatment for eye diseases  Oxford Observer

A Miami student's research may lead to a new treatment for glaucoma and macular degeneration. Phuong Thai Lam's work has earned her the Young ...

Vitamins, new treatments offer hope for people with macular degeneration  nwitimes.com

Macular degeneration is the leading cause of vision loss, affecting more than 10 million Americans — more than cataracts and glaucoma combined.

Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference  GlobeNewswire

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral presentation at ...

Macular Degeneration Treatment Market is Projected to Expand at a CAGR of 6.4% from 2018 to 2026  Financial Newspaper

Transparency Market Research (TMR) has published a new report titled “Macular degeneration treatment Market – Global Industry Analysis, Size, Share, Growth ...

Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness  Medical Xpress

Fight for Sight funded research published this week in Clinical Epigenetics, has identified new genes linked to the development of age-related macular ...

Juvenile Macular Degeneration Treatment Market Analysis and Growth 2019 | Copernicus Therapeutics Inc, Alkeus Pharmaceuticals Inc, Acucela Inc.  Daily Watch Reports

Latest Research Report On 'Global Juvenile Macular Degeneration Treatment Market 2019–2025' Included to Global Info Reports Database with Competitors, ...

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019  Insta Newsletters

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019. Summary. Reports Intellects clinical trial report, “Dry (Atrophic) Macular ...

Reducing the psychological distress of patients diagnosed with a common, retinal disease  EurekAlert

A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are ...

Age Related Macular Degeneration Treatment Market Research Report Analysis and F  News By ReportsGO

Global Age Related Macular Degeneration Treatment Market Report estimates the drivers, restraints, and opportunities pertaining to the Age Related Macular ...

The huge unmet medical need of dry AMD is expected to drive the market at a CAGR of over 8% during the forecast period  P&T Community

NEW YORK, July 24, 2019 /PRNewswire/ --. Global Age-Related Macular Degeneration (AMD) Therapeutics Market: About this market. Read the full report: ...

Regenxbio And RGX-501 In Homozygous Familial Hypercholesterolemia  Seeking Alpha

Liver Therapy Forum weekly digest provides an overview of what's happening in therapeutics for dyslipidemia in 2019. The focus this week is Regenxbio Inc. As ...

Temporal inverted ILM flap technique improves macular hole repair in wet or dry AMD eyes  Healio

CHICAGO — Patients coexisting with dry or wet age-related macular degeneration and macular holes experienced improved vision, anatomic and functional ...

Treatment for Wet Age-Related Macular Degeneration Receives Biologics License Application Approval  Pharmacy Times

Officials with the FDA have accepted Novartis' Biologics License Application (BLA) for brolucizumab (RTH258), a humanized single-chain antibody fragment ...

Implantable Miniature Telescope Market to Record an Exponential CAGR by 2025  Analytics News

Age-related macular degeneration (AMD) is a progressive retinal condition and is the leading cause of legal blindness in individuals over the age of 60 years.

7 Healthy Habits to Help Prevent Macular Degeneration  University of Michigan Health System News

AMD affects the eyesight of millions. A Michigan Medicine specialist offers easy ways to help slow or prevent the disease.

Age-Related Macular Degeneration: 5 Things to Know  Medscape

A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for.

What you need to know about wet macular degeneration  Medical Xpress

Millions of people deal with age-related macular degeneration as they get older, but many don't understand the difference between types of the condition or ...

Global Age Related Macular Degeneration Treatment Market Outlook 2019: Leading players Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche  SocioHerald

Actionable insights into Global Age Related Macular Degeneration Treatment Market 2019, covering overall product demand, sales revenue prospects, ...

The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study  Yahoo Finance

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 16) ACADIA ...

New laser shows promise in treating macular degeneration  WOWT

A breakthrough treatment for macular degeneration is being used on patients in the Rogue Valley. The Medford office using it is believed to be the only one West ...

Anti-angiogenic Ophthalmic Agents Market : Industry Trends and Developments 2017-2025  Rapid News Network

Global Anti-angiogenic Ophthalmic Agents Market: Overview. Anti-angiogenic ophthalmic agents mimic vascular endothelial growth factor (VEGF) antagonists.

Retinal Drugs And Biologics Market Comprehensive Review, Business Overview, Challenges, Opportunities, Trends Forecast to 2027  Commerce Gazette

Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the ...

Trial will be first in US of Nobel-winning stem cell technique  STAT

The NIH is planning the first U.S. clinical trial using induced pluripotent stem cells, to treat age-related macular degeneration.

3 Biotech Stocks That Soared Last Week  The Motley Fool

The biotech industry's summer doldrums are finally over and a handful of stocks recently posted some big gains for different reasons. Should we expect more ...

Seeing clearly: Know your risk for macular degeneration  Baylor College of Medicine News

Baylor College of Medicine's Dr. Christina Weng discusses what you need to know about macular degeneration.

Joshua Mali, MD: Evolution of Care for Macular Degeneration  MD Magazine

Medical Director of the Macular Degeneration Association discusses how the evolution of anti-VEGF treatments has changed the landscape of AMD care and ...

Age Related Macular Degeneration Treatment Market 2019 Future Growth with Worldwide Players- Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma  Insta Newsletters

The latest research Age Related Macular Degeneration Treatment Market 2019-2024. A detailed study accumulated to offer Latest insights about acute features ...

Can carrots help your eyes if you've been looking at your phone for too long?  Mirror Online

It's no secret that eyesight gets worse with age, but there are ways you can take care of your vision in later life…

A Local Ophthalmologist Uses New Technology to Restore Vision in Patients With Dry Macular Degeneration  Sarasota

In the 1970s TV show, “The Six-Million-Dollar Man,” Steve Austin had, among his many super-human implements, a bionic eye with a tiny telescope to enhance ...

Ollie's Infantry plans color run, barbecue to fight Batten's disease  Wahoo Newspaper

YUTAN – Oliver Egr is a giver, not a taker. While dealing with a rare disease called Juvenile Batten's Disease that has robbed him of his sight and begun to ...

Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patients  GlobeNewswire

Paris, July 18, 2019 – 07:00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable ...

Carl Regillo, MD: Brolucizumab as a Treatment for Macular Degeneration  MD Magazine

Investigators from Wills Eye and Retina Consultants of Austin presented 96-week data from the HAWK and HARRIER trials at ASRS 2019.

Boosting natural repair could help solve age related macular degeneration  PharmaTimes

Fight for Sight has announced funding for scientists at Queen's University Belfast. - News - PharmaTimes.

What Are Gunnar Glasses and Why Do You Need Them?  INQUIRER.net

Are you the type that spends lots of time behind the computer screen either for gaming purposes or for other important and unavoidable reasons? Spending a ...

Personalized 'eye-in-a-dish' models reveal genetic underpinnings of macular degeneration  Science Daily

Using stem cells derived from six people, researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants ...

Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others  Yahoo Finance

This week, the FDA granted approval to Glaxo's GSK asthma drug, Nucala for pediatric use. Meanwhile, Pfizer PFE, Allergan AGN and Roche RHHBY provided ...

Eye Health Ingredients Market 2019 Growth Analysis, Trends, Forecast 2024  News by Intelligence Journal

Eye Health Ingredients Market is projected to exceed USD 290 million by 2024 | driven by Increase in healthcare expenditure leading consumer interest over ...

Ophthalmic Lasers Market to Exhibit 5.3% CAGR Owing to Growing Global Demand for Medical Lasers |  Medgadget

The global ophthalmic lasers market reflects an impressive growth owing to the growing prevalence of refractive errors across the world. According to a.

Global Zeaxanthin Market Analysis by Manufacturers, Latest Trends, Competitive Landscape and Strategies 2026  US Trade Media

The global zeaxanthin market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the historic year of ...

Macular degeneration: Incurable, but progress being made  The San Diego Union-Tribune

For nearly 30 years, Marjorie Basnight has coped with fading vision. In the mid-1980s, she was diagnosed with “dry” macular degeneration. The disease slowly ...

Human Trials Could Begin for Macular Degeneration Stem Cell Therapy  MD Magazine

FDA trial approval would make this trial the first ever to test a stem cell-based therapy derived from induced pluripotent stem cells for treating any disease.

Global Ophthalmic Surgical Instruments Market Valuable Growth Prospects, Top Players, Key Country Analysis, Trends and Forecast till 2025  Rapid News Network

Report Ocean has released a new business intelligence report on “Global Ophthalmic Surgical Instruments Market”. Report provides an in-depth market analysis ...

Aerie Pharmaceuticals Submits Prior Approval Supplement to the U.S. Food and Drug Administration to Allow Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in its Athlone Ireland Facility  Yahoo Finance

Aerie Pharmaceuticals, Inc. (AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class ...

Asia-Pacific Ophthalmic Surgical Instruments Market Valuable Growth Prospects, Top Players, Key Country Analysis, Trends and Forecast till 2025  Rapid News Network

Report Ocean has released a new business intelligence report on “Asia-Pacific Ophthalmic Surgical Instruments Market”. Report provides an in-depth market ...

Fresh insights into genes and macular degeneration could open new treatment pathways  FierceBiotech

NIH researchers have pinpointed 6 genomic regions that are closely associated with the development of age-related macular degeneration. (Pixabay).

Gemini Therapeutics Announces Leadership Appointment  Business Wire

Gemini Therapeutics announced the appointment of Jason Meyenburg, MBA, as Chief Executive Officer.

Clinical Catch-Up: September 9-13  BioSpace

Last week was a busy one for clinical trial results, particularly with the European Committee for Treatment and Research in Multiple Sclerosis 2019 Congress ...

Intraoperative surgical methods hold key to AMD treatment  Modern Retina

Intraoperative fundus image and intraoperative OCT obtained with a commercially available operating microscope (OPMI LUMERA 700 and RESCAN 700; Carl ...

PMI Forecasts a Booming Opthalmic Drugs Market by 2029  SocioHerald

The report examination the main players of the Global Opthalmic Drugs Market by investigating their market share, late improvements, new item dispatches, ...

Gene Therapy For Age-related Macular Degeneration Market Global Insights 2019, Forecast to 2025  Market Research Headlines

MarketInsightsReports has announced the addition of the “Global Gene Therapy For Age-related Macular Degeneration Market Research Report” The report ...

LumiThera receives $2.5 million grant to study dry AMD treatment option  Healio

LumiThera has received a $2.5 million small business innovative research phase II grant from the National Institute of Health and the National Eye Institute to ...

Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness  Healio

Researchers have completed the first gene therapy procedure aimed at stopping age-related macular degeneration.The operation was performed at John ...

Senior Living: Macular degeneration and what it means for you  Long Beach Press Telegram

Loss in vision as you age is common among older adults, but not something you should take lightly or ignore. Problems with your vision can be a sign of a new ...

» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America